Constipation Management in Infants

Initial Management Approach

The American Academy of Pediatrics recommends sorbitol-containing fruit juices, such as prune, pear, or apple juice, as the first-line treatment for constipation in 4-month-old infants, as they increase stool frequency and water content 1
Ensuring the infant continues breast-feeding on demand or receives full-strength formula with adequate hydration is a safe and often effective approach for mild constipation in this age group 1

Glycerin suppositories are the preferred pharmacologic option for infants under 6 months if dietary measures fail, as they work as rectal stimulants through mild irritant action and are safe for this young age group 1
The use of bisacodyl is not recommended in infants under 6 months due to lack of safety and efficacy data, and safer alternatives are available 1
Docusate (stool softeners) are not recommended as they have shown no benefit even in older populations 2
Stimulant laxatives are not appropriate as first-line therapy in any pediatric age group 1

Digital rectal examination is necessary to rule out signs of obstruction or impaction before treating constipation in infants 1
Phosphate enemas should not be used in infants due to the risk of electrolyte abnormalities 2
Suppositories or enemas should be avoided in infants with thrombocytopenia, recent surgery, or anal trauma 1

Lactulose acts as an osmotic laxative by drawing water into the intestinal lumen, increasing stool water content; it is not absorbed from the gastrointestinal tract, providing a safe, locally acting therapy for infants with functional constipation. 3

Prior to starting any laxative in infants, clinicians should evaluate for reversible causes of constipation—such as hypothyroidism or anatomical abnormalities—to ensure that lactulose is used appropriately and not masking an underlying disorder. 4

The most frequently reported side‑effects of lactulose in infants are abdominal cramping, bloating, and flatulence; these symptoms typically appear within the first 2–3 days of therapy and should be distinguished from treatment failure. 3

Clinical success of lactulose therapy is defined by the achievement of regular, non‑forced bowel movements without straining, indicating restored colonic motility and adequate stool passage. 4